Allogene Therapeutics, Inc. - Common Stock (ALLO)
CUSIP: 019770106
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 228,416,724
- Total 13F shares
- 130,384,371
- Share change
- -3,352,706
- Total reported value
- $413,319,837
- Put/Call ratio
- 707%
- Price per share
- $3.17
- Number of holders
- 152
- Value change
- -$17,479,237
- Number of buys
- 79
- Number of sells
- 65
Quarterly Holders Quick Answers
What is CUSIP 019770106?
CUSIP 019770106 identifies ALLO - Allogene Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 019770106:
Top shareholders of ALLO - Allogene Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
11%
|
24,917,955
|
$123,842,236 | — | 30 Jun 2023 | |
| TPG GP A, LLC |
13F
3/4/5
|
Company · 10%+ Owner |
8.2%
|
18,716,306
|
$93,020,041 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
3.7%
|
8,478,761
|
$42,139,442 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.7%
|
8,446,050
|
$41,976,869 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.3%
|
7,501,493
|
$37,282,420 | — | 30 Jun 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.7%
|
6,134,395
|
$30,487,943 | — | 30 Jun 2023 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
2.5%
|
5,636,686
|
$28,014,329 | — | 30 Jun 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.3%
|
5,331,400
|
$26,498,000 | — | 30 Jun 2023 | |
| Woodline Partners LP |
13F
|
Company |
2.3%
|
5,313,500
|
$26,408,095 | — | 30 Jun 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.1%
|
4,740,341
|
$23,559,495 | — | 30 Jun 2023 | |
| EcoR1 Capital, LLC |
13F
|
Company |
2%
|
4,488,200
|
$22,306,354 | — | 30 Jun 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.85%
|
1,952,780
|
$9,705,317 | — | 30 Jun 2023 | |
| Wildcat Capital Management, LLC |
13F
|
Company |
0.84%
|
1,920,787
|
$9,546,311 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.8%
|
1,827,782
|
$9,084,081 | — | 30 Jun 2023 | |
| Vida Ventures Advisors, LLC |
13F
|
Company |
0.79%
|
1,798,163
|
$8,936,870 | — | 30 Jun 2023 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.69%
|
1,576,901
|
$7,837,198 | — | 30 Jun 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.66%
|
1,499,972
|
$7,454,861 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.58%
|
1,331,437
|
$6,617,242 | — | 30 Jun 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.57%
|
1,292,141
|
$6,419,750 | — | 30 Jun 2023 | |
| Eric Thomas Schmidt |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
2,447,772
mixed-class rows
|
$6,396,524 | — | 22 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.53%
|
1,214,700
|
$6,037,059 | — | 30 Jun 2023 | |
| Swedbank AB |
13F
|
Company |
0.44%
|
1,000,000
|
$4,970,000 | — | 30 Jun 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.39%
|
884,571
|
$4,396,318 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.38%
|
862,506
|
$4,286,656 | — | 30 Jun 2023 | |
| NORGES BANK |
13F
|
Company |
0.34%
|
769,120
|
$3,822,526 | — | 30 Jun 2023 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.34%
|
775,295
|
$3,729,169 | — | 30 Jun 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.31%
|
715,469
|
$3,555,881 | — | 30 Jun 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.29%
|
669,197
|
$3,325,910 | — | 30 Jun 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.29%
|
665,331
|
$3,306,695 | — | 30 Jun 2023 | |
| Cerity Partners LLC |
13F
|
Company |
0.26%
|
598,100
|
$2,972,557 | — | 30 Jun 2023 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.23%
|
533,236
|
$2,634,185 | — | 30 Jun 2023 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.22%
|
510,054
|
$2,534,968 | — | 30 Jun 2023 | |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP |
13F
|
Company |
0.2%
|
454,845
|
$2,260,580 | — | 30 Jun 2023 | |
| Alison Moore |
3/4/5
|
Chief Technical Officer |
—
mixed-class rows
|
1,105,469
mixed-class rows
|
$2,135,517 | — | 22 Mar 2023 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.19%
|
427,752
|
$2,126,000 | — | 30 Jun 2023 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.18%
|
412,000
|
$2,047,640 | — | 30 Jun 2023 | |
| Coastal Bridge Advisors, LLC |
13F
|
Company |
0.18%
|
406,847
|
$2,022,030 | — | 30 Jun 2023 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.17%
|
395,723
|
$1,956,557 | — | 30 Jun 2023 | |
| Veer Bhavnagri |
3/4/5
|
General Counsel |
—
class O/S missing
|
556,049
|
$1,765,122 | — | 14 Mar 2023 | |
| Rafael Amado |
3/4/5
|
EVP of R&D |
—
class O/S missing
|
541,946
|
$1,720,353 | — | 07 Oct 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.15%
|
337,976
|
$1,679,741 | — | 30 Jun 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.15%
|
336,864
|
$1,674,214 | — | 30 Jun 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.14%
|
308,886
|
$1,535,163 | — | 30 Jun 2023 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.13%
|
300,000
|
$1,491,000 | — | 30 Jun 2023 | |
| UBS Group AG |
13F
|
Company |
0.13%
|
297,012
|
$1,476,149 | — | 30 Jun 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.12%
|
281,364
|
$1,398,379 | — | 30 Jun 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.12%
|
275,848
|
$1,370,965 | — | 30 Jun 2023 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.11%
|
261,623
|
$1,300,266 | — | 30 Jun 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.11%
|
251,900
|
$1,252,000 | — | 30 Jun 2023 | |
| Simplify Asset Management Inc. |
13F
|
Company |
0.11%
|
245,000
|
$1,217,650 | — | 30 Jun 2023 |
Institutional Holders of Allogene Therapeutics, Inc. - Common Stock (ALLO) as of Q3 2023
As of 30 Sep 2023,
Allogene Therapeutics, Inc. - Common Stock (ALLO) was held by
152 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
130,384,371 shares.
The largest 10 holders included
FMR LLC, TPG GP A, LLC, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, JPMORGAN CHASE & CO, Woodline Partners LP, PRIMECAP MANAGEMENT CO/CA/, EcoR1 Capital, LLC, and CITADEL ADVISORS LLC.
This page lists
152
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
168
Q3 2023 holders
152
Holder diff
-16
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.